• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲流脑现状及全球流脑倡议对新病例定义的建议。

The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative.

机构信息

FCM da Santa Casa de São Paulo, Alameda dos Indigenas, 228, ZIP 04059 060, São Paulo, Brazil.

出版信息

Expert Rev Vaccines. 2013 Aug;12(8):903-15. doi: 10.1586/14760584.2013.814879. Epub 2013 Aug 5.

DOI:10.1586/14760584.2013.814879
PMID:23909747
Abstract

The Global Meningococcal Initiative (GMI) is an international group of scientists and clinicians with expertise in meningococcal disease (MD). It promotes MD prevention through education and research. Given geographic differences in disease epidemiology, prevention strategies (e.g., vaccination) should be country-specific to ensure local needs are met. However, regional policies/recommendations and standardized disease diagnostic criteria should be implemented to improve surveillance and control strategies, and allow for more robust data comparisons. Consequently, the GMI convened a meeting with Latin American representatives to discuss the burden of MD and vaccination practices/policies, and consider if the global GMI recommendations could be tailored. The group determined that as robust, uniform epidemiologic data are required to make informed health-policy decisions, it would be useful to first summarize the regional situation herein (including disease surveillance, case definitions, epidemiology, vaccination and outbreak control strategies) and then determine a consensus-based meningococcal case definition for use throughout the region.

摘要

全球脑膜炎球菌倡议(GMI)是一个由脑膜炎球菌病(MD)领域的科学家和临床医生组成的国际团体。它通过教育和研究促进 MD 的预防。鉴于疾病流行病学的地理差异,预防策略(例如疫苗接种)应该针对特定国家,以确保满足当地的需求。然而,应该实施区域政策/建议和标准化疾病诊断标准,以改进监测和控制策略,并允许进行更有力的数据比较。因此,GMI 召集了一次拉丁美洲代表会议,讨论 MD 的负担和疫苗接种实践/政策,并考虑是否可以调整全球 GMI 的建议。该小组确定,由于需要可靠、统一的流行病学数据来做出明智的卫生政策决策,因此首先总结该地区的情况(包括疾病监测、病例定义、流行病学、疫苗接种和暴发控制策略),然后确定一个基于共识的脑膜炎球菌病例定义,以便在整个地区使用,这将是有用的。

相似文献

1
The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative.拉丁美洲流脑现状及全球流脑倡议对新病例定义的建议。
Expert Rev Vaccines. 2013 Aug;12(8):903-15. doi: 10.1586/14760584.2013.814879. Epub 2013 Aug 5.
2
The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations.拉丁美洲脑膜炎球菌病的现状及全球脑膜炎球菌病倡议(GMI)的最新建议。
Vaccine. 2015 Nov 27;33(48):6529-36. doi: 10.1016/j.vaccine.2015.10.055. Epub 2015 Oct 25.
3
The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.全球流脑倡议:降低全球流脑疾病负担的建议。
Vaccine. 2011 Apr 18;29(18):3363-71. doi: 10.1016/j.vaccine.2011.02.058. Epub 2011 Mar 3.
4
Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative.亚太地区的脑膜炎球菌病:全球脑膜炎球菌病倡议的研究结果与建议
Vaccine. 2016 Nov 21;34(48):5855-5862. doi: 10.1016/j.vaccine.2016.10.022. Epub 2016 Oct 22.
5
A consensus statement: meningococcal disease among infants, children and adolescents in Latin America.一份共识声明:拉丁美洲婴幼儿、儿童及青少年中的脑膜炎球菌病
Pediatr Infect Dis J. 2014 Mar;33(3):284-90. doi: 10.1097/INF.0000000000000228.
6
An overview of meningococcal disease in India: knowledge gaps and potential solutions.印度脑膜炎奈瑟菌病概述:知识差距与潜在解决方案。
Vaccine. 2013 Jun 7;31(25):2731-7. doi: 10.1016/j.vaccine.2013.04.003. Epub 2013 Apr 12.
7
Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI).中国的脑膜炎球菌病与控制:全球脑膜炎球菌倡议(GMI)的研究结果与最新进展。
J Infect. 2018 May;76(5):429-437. doi: 10.1016/j.jinf.2018.01.007. Epub 2018 Feb 12.
8
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.全球脑膜炎球菌倡议会议:全球预防脑膜炎球菌病:流行病学、监测、高毒力菌株、抗生素耐药性和高危人群。
Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27.
9
Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.流脑的流行病学和预防:疫苗政策的批判性评估。
Expert Rev Vaccines. 2011 Dec;10(12):1717-30. doi: 10.1586/erv.11.159.
10
Can we defeat meningococcal disease in low and middle income countries?我们能否在中低收入国家战胜脑膜炎球菌病?
Vaccine. 2012 May 30;30 Suppl 2:B63-6. doi: 10.1016/j.vaccine.2011.12.063.

引用本文的文献

1
Trends in Neisseria meningitidis serogroups amongst patients with suspected cerebrospinal meningitis in the meningitis belt of Ghana: a 5-year retrospective study.加纳脑膜炎带疑似脑膜炎患者中脑膜炎奈瑟菌血清群的流行趋势:一项为期 5 年的回顾性研究。
BMC Infect Dis. 2023 Apr 6;23(1):202. doi: 10.1186/s12879-023-08196-x.
2
A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions.巴西 B 群脑膜炎球菌病负担的批判性分析(2001-2015):对公共卫生决策的影响。
Hum Vaccin Immunother. 2020 Aug 2;16(8):1945-1950. doi: 10.1080/21645515.2019.1700710. Epub 2020 Jan 17.
3
Estimation of the real burden of invasive meningococcal disease in Argentina.
估计阿根廷侵袭性脑膜炎球菌病的实际负担。
Epidemiol Infect. 2019 Nov 29;147:e311. doi: 10.1017/S0950268819002024.
4
Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.B 群脑膜炎奈瑟球菌疾病的全球流行病学和新型重组蛋白疫苗预防的机会。
Hum Vaccin Immunother. 2018 May 4;14(5):1042-1057. doi: 10.1080/21645515.2018.1458175. Epub 2018 Apr 30.
5
Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults.健康青少年和年轻成人接种五价 MenABCWY 疫苗后的四年抗体持久性和加强剂量应答。
Hum Vaccin Immunother. 2018 May 4;14(5):1161-1174. doi: 10.1080/21645515.2018.1457595. Epub 2018 May 9.
6
Challenges and opportunities for meningococcal vaccination in the developing world.发展中国家脑膜炎球菌疫苗接种的挑战与机遇。
Hum Vaccin Immunother. 2018 May 4;14(5):1084-1097. doi: 10.1080/21645515.2018.1434463. Epub 2018 Feb 23.
7
Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil.从巴西萨尔瓦多11至19岁脑膜炎球菌携带者中分离出的脑膜炎奈瑟菌菌株的分子特征分析。
PLoS One. 2017 Sep 20;12(9):e0185038. doi: 10.1371/journal.pone.0185038. eCollection 2017.
8
A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1-24 years in the city of Embu das Artes, São Paulo, Brazil.一项横断面研究,评估巴西圣保罗州恩布达斯阿尔蒂斯市1至24岁人群中脑膜炎奈瑟菌的咽部携带情况。
Braz J Infect Dis. 2017 Nov-Dec;21(6):587-595. doi: 10.1016/j.bjid.2017.06.005. Epub 2017 Jul 14.
9
Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease.全球脑膜炎球菌倡议组织:侵袭性脑膜炎球菌病的诊断与确诊指南
Epidemiol Infect. 2016 Oct;144(14):3052-3057. doi: 10.1017/S0950268816001308. Epub 2016 Jun 30.
10
Economic Impact of Meningococcal Outbreaks in Brazil and Colombia.巴西和哥伦比亚脑膜炎球菌病疫情的经济影响。
Open Forum Infect Dis. 2015 Nov 12;2(4):ofv167. doi: 10.1093/ofid/ofv167. eCollection 2015 Dec.